Abstract:DNA is commonly known as the "molecule of life" because it holds the genetic instructions for all living organisms on Earth. The utilization of modified nucleosides holds the potential to transform the management of a wide range of human illnesses. Modified nucleosides and their role directly led to the 2023 Nobel prize. Acyclic nucleosides, due to their distinctive physiochemical and biological characteristics, rank among the most adaptable modified nucleosides in the field of medicinal chemistry. Acyclic nucleosides are more resistant to chemical and biological deterioration, and their adaptable acyclic structure makes it possible for them to interact with various enzymes. A phosphonate group, which is linked via an aliphatic functionality to a purine or a pyrimidine base, distinguishes acyclic nucleoside phosphonates (ANPs) from other nucleotide analogs. Acyclic nucleosides and their derivatives have demonstrated various biological activities such as anti-viral, anti-bacterial, anti-cancer, anti-microbial, etc. Ganciclovir, Famciclovir, and Penciclovir are the acyclic nucleoside-based drugs approved by FDA for the treatment of various diseases. Thus, acyclic nucleosides are extremely useful for generating a variety of unique bioactive chemicals. Their biological activities as well as selectivity is significantly influenced by the stereochemistry of the acyclic nucleosides because chiral acyclic nucleosides have drawn a lot of interest due to their intriguing biological functions and potential as medicines. For example, tenofovir's ( R ) enantiomer is roughly 50 times more potent against HIV than its ( S ) counterpart. We can confidently state, "The most promising developments are yet to come in the realm of acyclic nucleosides!" Herein, we have covered the most current developments in the field of chemical synthesis and therapeutic applications of acyclic nucleosides based upon our continued interest and activity in this field since mid-1990's.

Late-Stage Functionalization of Guanine-Based Nucleosides, Nucleotides, and Oligonucleotide: Synthesis and Derivatization of Tricyclic Nucleoside Analogues

Synthesis of Janus Type Nucleoside Analogues and Their Preliminary Bioactivity

Acid‐Promoted Cyclization Reaction of the Guanine Base with 1,1,3,3‐Tetramethoxypropane: A Method for the Preparation of M1dG and its Derivatives

Late-stage guanine C8–H alkylation of nucleosides, nucleotides, and oligonucleotides via photo-mediated Minisci reaction

Recent Progress in the Syntheses of Carbocyclic Nucleosides

Synthesis of Nucleoside Analogues with Aromatic Systems Appended on the Triazole Nucleobase

Design and Synthesis of Bicyclo[4.3.0]nonene Nucleoside Analogues

Synthesis of Antiviral Acyclic C-nucleosides Incorporating 4-Thiazolinones Structure

Synthesis of 1,2,3- Triazole Nucleoside Analogues

Direct C-glycosylation of guanine analogues: the synthesis and antiviral activity of certain 7- and 9-deazaguanine C-nucleosides

The Syntheses of Pyrimido-Pyridazinone and Pyrrolidino-Pyrimidinone 2 '-Deoxynucleoside Derivatives

Recent Advances in the Synthesis of Acyclic Nucleosides and Their Therapeutic Applications

A short de novo synthesis of nucleoside analogs

Synthesis and Bioactivity of Novel Trisubstituted Triazole Nucleosides.

Nucleobase-Functionalized 7-Deazaisoguanine and 7-Deazapurin-2,6-diamine Nucleosides: Halogenation, Cross-Coupling, and Cycloaddition

Advance of Structural Modification of Nucleosides Scaffold

Preparation of Bicyclo[1.1.1]pentane-Derived Nucleoside Analogues

Synthetic Methodologies for<i>C</i>-Nucleosides

An improved synthesis of guanosine TNA phosphoramidite for oligonucleotide synthesis

Synthesis of 4'-Thionucleoside Analogues Bearing a C2' Stereogenic All-Carbon Quaternary Center

The hydrazine moiety in the synthesis of modified nucleosides and nucleotides